Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Medical Oncology|March 10, 2023
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancerPier Vitale Nuzzo, Francesco Ravera, Calogero Saieva, et al.
European Urology Oncology|February 6, 2025
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends SurveyAnna Patrikidou, Christoph Oing, Christos Markellos, et al.
Neuro-Oncology|February 13, 2019
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patientsDenis Migliorini, Valérie Dutoit, Mathilde Allard, et al.
Cancers|April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint InhibitorsSara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
The Oncologist|June 24, 2018
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)Loïc Chaigneau, Anna Patrikidou, Isabelle Ray-Coquard, et al.
Current Oncology Reports|July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive ReviewLaurent Mathiot, Capucine Baldini, Octave Letissier, et al.
BMC Cancer|February 14, 2020
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)Anna Patrikidou, Loic Chaigneau, Nicolas Isambert, et al.
Cancer Medicine|November 13, 2019
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
Clinical Genitourinary Cancer|August 31, 2024
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 StudyGiuseppe Fotia, Calogero Saieva, Richard Lee-Ying, et al.
Pageof 8